Concepedia

Priya Koppikar

PK

21

Publications

2.5K

Citations

20

H-Index

2004

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kettering University

University of Pittsburgh

The University of Texas MD Anderson Cancer Center

Harvard University

Priya Koppikar is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingImmunologyJak-stat Signaling PathwayOncologyHematologyTumor BiologyCancer ResearchNatural Sciences

Publications per year

2004–2025

21

Publications

21

Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Priya Koppikar, Neha Bhagwat, Outi Kilpivaara et al. · Nature · 2012 · 359 citations · Full text

JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response

Maria Kleppe, Minsuk Kwak, Priya Koppikar et al. · Cancer Discovery · 2015 · 302 citations · Full text

JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation

Fan Liu, Xinyang Zhao, Fabiana Perna et al. · Cancer Cell · 2011 · 261 citations · Full text

Signaling Pathway, Medicine, Genetics +11

HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans

Sachie Marubayashi, Priya Koppikar, Tony Taldone et al. · Journal of Clinical Investigation · 2010 · 178 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +16

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Sara C. Meyer, Matthew D. Keller, Sophia Chiu et al. · Cancer Cell · 2015 · 151 citations

Rows per page

1–5 of 21